A new test for mesothelioma was developed and released earlier this year. The test, known as miRview meso, allows physicians to distinguish between mesothelioma and other lung cancer. Both forms of cancer can be caused by asbestos exposure and have similar outward symptoms, making it difficult to tell the difference in many cases.
On April 30, the company that created the test, Rosetta Genomics, announced its licensing agreement with Prometheus Labs. Prometheus Labs will now have the rights to producing the microRNA based test as well as two other tests created by Rosetta Genomics. The test will be a great benefit to people who suffer from mesothelioma.
If you or someone you know has been diagnosed with mesothelioma, contact the mesothelioma attorneys of Williams Kherkher at 800-781-3955.